The Primary objective of this registry is to assess the control of Atrial Fibrillation (AF) over one year in patients attending clinical or specialized practices. The Secondary objectives are: * To describe key demographics and treatment features in AF patients visiting cardiologists in various countries in Asia-Pacific. * To establish correlation between control of AF and clinical outcomes. * To establish correlation between treatment strategies and AF control.
Study Type
OBSERVATIONAL
Enrollment
2,674
Sanofi-Aventis Administrative Office
Macquarie Park, Australia
Sanofi-Aventis Administrative Office
Shanghai, China
Sanofi-Aventis Administrative Office
Hong Kong, Hong Kong
Sanofi-Aventis Administrative Office
Kuala Lumpur, Malaysia
Rate of therapeutic success by patients in sinus rhythm or heart rate control at target (< 80 beats per minute at rest)
Time frame: At 12 ± 3 months follow-up
Comparison of clinical outcomes (Cardiovascular death, Stroke, Myocardial infarction, etc) for patients in rhythm versus rate control strategies
Time frame: At 12 ± 3 months follow-up
Treatment effectiveness evaluated by the proportion of patients in sinus rhythm
Time frame: At 1 year follow-up
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Sanofi-Aventis Administrative Office
Makati City, Philippines
Sanofi-Aventis Administrative Office
Seoul, South Korea
Sanofi-Aventis Administrative Office
Taipei, Taiwan
Sanofi-Aventis Administrative Office
Bangkok, Thailand